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Oligodendrocyte-type 2 astrocyte (O-2A) lineage cells are de-
rived from multipotential stem cells of the developing CNS.
Precursors of O-2A progenitors express the polysialylated
(PSA) form of the neural cell adhesion molecule (NCAM) and are
detected in neonatal rat brain glial cultures. It is unclear how
such PSA-NCAM1 “pre-progenitors” are related to neural stem
cells and whether they still have the potential to differentiate
along several neural lineages. Here we isolated PSA-NCAM1
pre-progenitor cells from glial cultures by immunopanning and
found that most of these cells expressed nestin and PDGF-
receptor-a but not O-2A antigens. PSA-NCAM1 cells synthe-
sized transcripts for fibroblast growth factor (FGF) receptors 1,
2, and 3 and responded to FGF2 by survival and proliferation,
growing into large clusters resembling neural spheres. FGF2-
induced proliferation of PSA-NCAM1 pre-progenitors was sig-
nificantly enhanced by thyroid hormone (T3), which on its own
did not increase cell survival or mitosis. After adhesion and
withdrawal of the mitogen, spheres generated mostly oligoden-
drocytes and astrocytes but very rarely neurons. PSA-NCAM
immunopanned cells grown in epidermal growth factor (EGF)
also adopted a mostly glial fate after differentiation. In contrast,
PSA-NCAM-negative cells and striatal neonatal stem cells,
grown in EGF or FGF2, generated the three CNS cell types. Like
neural stem cells, PSA-negative cells generated more oligoden-
drocytes and fewer neurons when expanded in FGF2 and T3.
Thus emergence of PSA-NCAM at the surface of neonatal brain
precursors coincides with their restriction to a glial fate. T3
modulates these events by enhancing PSA-NCAM1 pre-
progenitor growth in FGF2 and favoring an oligodendrocyte
fate.
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The three major CNS cell types emerge on a precise time
schedule from proliferating neuroepithelial cells in the ventricular
zone during embryonic and neonatal development. Multipoten-
tial neural stem cells can be isolated from CNS starting at em-
bryonic day 12 until adulthood (Williams et al., 1991; Reynolds
and Weiss, 1992; Davis and Temple, 1994; Gritti et al., 1996; Johe
et al., 1996). In the newborn rodent CNS, most neurons have
already been generated, whereas glial progenitors are actively
proliferating. Whether oligodendrocytes and astrocytes emerge at
this stage from a common glial precursor or from distinct precur-
sor cells is being actively investigated (Price, 1994; Goldman,
1996). The most extensively studied glial precursor is the
oligodendrocyte-type 2 astrocyte (O-2A) progenitor isolated
from neonatal optic nerve (Raff et al., 1983; Raff, 1989). This
bipolar cell expresses membrane gangliosides such as GD3 (Gold-
man et al., 1984) and those recognized by the monoclonal anti-
body A2B5 (Eisenbarth et al., 1979; Raff et al., 1983). Type 2
astrocytes express glial fibrillary acidic protein (GFAP) as well as
gangliosides characteristic of these progenitors but are rarely
encountered during CNS development in vivo. Type 1 astrocytes
are characterized in vitro by a GFAP1, A2B52 antigenic pheno-
type, and they originate from immature astroblasts arising from
the subventricular zone during late embryonic and early postnatal
periods (for review, see Goldman, 1996).
Development of the O-2A lineage is controlled by growth
factors and hormones acting via membrane-associated and nu-
clear receptors. O-2A proliferation and migration can be medi-
ated by platelet-derived growth factor (PDGF) in vitro (Raff et al.,
1988; Richardson et al., 1988; Armstrong et al., 1990). Basic
fibroblast growth factor (FGF2) is also mitogenic for O-2A pro-
genitors alone or in synergism with PDGF, blocking their differ-
entiation into oligodendrocytes (Bogler et al., 1990; McKinnon et
al., 1990). As O-2A progenitors mature, they become multipolar
and start to express sulfatide and other membrane-associated
antigens that are recognized by the monoclonal antibody O4
(Sommer and Shachner, 1981; Bansal et al., 1989; for review, see
Pfeiffer et al., 1994). Thyroid hormone limits the number of O-2A
cell divisions and allows them to enter the differentiation stage
(Barres et al., 1994). This hormone also promotes myelination
and synthesis of the myelin proteolipid protein and basic protein
in oligodendrocytes (Almazan et al., 1985; Farsetti et al., 1991;
Baas et al., 1997).
To determine whether neural stem cells generate bipotential or
distinct unipotential glial precursors, we characterized the stage
of development between multipotential, self-renewing stem cells
and committed O-2A progenitors. Precursors of O-2A cells have
been identified in neonatal rat primary glial cultures and were
shown to generate O-2A progenitors (Grinspan et al., 1990;
Hardy and Reynolds, 1991). These small, round, proliferating
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“pre-progenitor” cells are responsive to PDGF and express the
embryonic polysialylated form of the neural cell adhesion mole-
cule (PSA-NCAM) before O-2A progenitor antigens emerge
(Grinspan and Franceschini, 1995). In this study, we have further
characterized these pre-progenitor cells that proliferated and
formed cell clusters or spheres in response to FGF2 or EGF.
These cells expressed both FGF and thyroid receptor genes
(THRs), and addition of T3, the active form of thyroid hormone,
enhanced the mitogenic effect of FGF2. We then compared the
fate of these neonatal PSA-NCAM1 precursors to that of striatal
neural stem cells and to PSA-NCAM negative precursors ex-
panded with EGF or FGF2 in neurospheres (Weiss et al., 1996).
After adhesion, PSA-NCAM1 clusters generated almost exclu-
sively cells of the oligodendrocyte lineage and astrocytes, whereas
the other precursors or stem cells were multipotential, giving rise
to neurons, astrocytes, and oligodendrocytes. Thus emergence of
PSA-NCAM at the surface of neonatal brain precursors coincides
with their restriction to a mostly glial fate. T3 modulates these
events by enhancing PSA-NCAM1 pre-progenitor growth in
FGF2 and favoring an oligodendrocyte fate.
MATERIALS AND METHODS
Preparation of mixed glial cultures. Sprague Dawley newborn rats were
anesthetized by hypothermia and then killed by rapid decapitation. The
cerebral hemispheres, including deep nuclei, white matter, and subven-
tricular zones, were isolated, and the cerebellum and brainstem were
discarded. After removal of meninges, the tissue was minced, digested in
0.025% Trypsin for 20 min, and mechanically dissociated with a 5 ml
pipette to obtain a single-cell suspension. Debris were removed by
centrifugation through a 4% BSA (Sigma, Paris, France) layer. The cells
were suspended in DMEM supplemented with 5% FCS (both from Life
Technologies, Eragny, France) and plated onto T-75 flasks (Costar,
Badhoeverdorp, The Netherlands), coated with 10 mg/ml poly-D-lysine
(Sigma) at a density of 3.5–4 3 10 7 cells/flask.
Isolation and culture of PSA-NCAM-positive and PSA-NCAM-negative
cells. Oligodendrocyte lineage cells were enriched from mixed glial
cultures by the shaking method before PSA-NCAM1 cells were isolated
by immunopanning (Grinspan and Franceschini, 1995). Briefly, 100 mm
Falcon Optilux Petri dishes were first coated with secondary antibody
(goat anti-mouse IgM, m-chain specific, Chemicon, Temecula, CA) at 5
mg/ml in 50 mM Tris-HCl, pH 9.5, for 18 hr at 4°C. The plates were then
washed three times in PBS and coated with anti-PSA-NCAM antibody
[anti-Men-B antibody (Rougon et al., 1986)] at 1:250 dilution in PBS with
0.2% BSA at room temperature for at least 1 hr.
After 2–3 d in vitro, the T-75 flasks containing the primary brain cells
were placed on a rotary shaker at 37°C for 30 min at 140 rpm in the
presence of 5 mM L-leucine methyl ester (Sigma) to eliminate the micro-
glia. The medium was then replaced and equilibrated with CO2 , and the
flasks were shaken overnight at 200 rpm. Detached cells were plated on
tissue culture dishes for 30 min to allow attachment of residual microglia
and astrocytes. The floating cells were then collected and plated at 5 3
10 6 cells/100 mm dish coated for PSA-immunopanning and allowed to
bind at 37°C for 30 min. In the majority of experiments, nonadherent
cells were washed off extensively before the adherent, PSA-NCAM1
cells were removed by trypsinization, washed three times, and resus-
pended in serum-free, modified N2 medium (see below). Cell viability
after shaking and immunopanning was $90% by trypan blue exclusion
test. In some experiments, nonadherent cells that were not adhering to
the anti-PSA antibody-coated dish were collected, centrifuged (400 3 g,
8 min at room temperature), and then washed three times to remove any
of the remaining FCS. These were also resuspended in a serum-free,
modified N2 medium,.
PSA-NCAM-positive or -negative cells were then plated on 35 mm
tissue culture dishes (Falcon, Le Pont-de Claix, France), Labtek multi-
well (Nunc, Life Technologies, Eragny, France), or in 96-well plates
(Costar, Cambridge, MA) at a density of 30 3 10 3 cells/cm 2. Modified
N2 medium consisted of DMEM, 5 mg% human apo-transferrin, 1 mM
sodium pyruvate, 0.05% BSA, 10 ng/ml D-biotin, 30 nM sodium selenite,
10 nM hydrocortisone, 15 nM triiodo-L-thyronine (T3), 5 mg/ml of bovine
insulin, and 25 mg/ml of gentamycin. In some experiments (as detailed in
the text), T3 was omitted from the medium. DMEM and sodium pyru-
vate were from Life Technologies and all other factors from Sigma. In
various experiments, 10 ng/ml (or other concentrations if specifically
mentioned) human FGF2, human EGF, or PDGF-AB (those three
factors were a generous gift of Amgen, Thousand Oaks, Ca) were added.
Isolation and culture of newborn striatum neural stem cells. One-day-old
Sprague Dawley newborn rats were anesthetized and rapidly killed by
cervical transection. Cerebral hemispheres, freed of meninges, were
placed in an HBSS solution, and striata including subependyma were
dissected out. Tissue was minced with a scalpel blade, transferred in
DMEM/F12 (1:1, v/v; Life Technology), and triturated by passing
through a fire-polished Pasteur pipette. The cell suspension was then
filtered through a 70 mm nylon mesh, and 10 6 viable cells were plated in
20 ml of medium in an uncoated T25 tissue culture flask (Costar). The
culture medium consisted of DMEM/F12 supplemented with B27 (Life
Technology), 25 mg/ml of bovine insulin, 100 mg/ml of transferrin, 20 nM
progesterone, 60 mM putrescin, 30 nM sodium selenite, and 20 ng/ml of
EGF or 10 ng/ml of FGF2. In some cases, 15 nM T3 was added. Every 3 d,
half of the medium was renewed. After 1 week, numerous spheres had
grown in these conditions.
Adhesion of spheres or clusters. Striata neural stem cell clusters were
transferred by pipetting onto polyornithine-coated 35 mm dishes at low
density (polyornithine was from Sigma and used at 100 mg/ml). The
culture medium remained unchanged except that EGF or bFGF was
omitted, and after 3–5 d, cultures were formaldehyde-fixed and processed
for immunocytofluorescence.
PSA-NCAM-positive and -negative clusters and spheres that were
grown for 2 weeks on uncoated dishes in defined medium supplemented
with FGF2 and T3 were collected by gentle pipetting and transferred to
polyornithine-coated dishes or coverslips at low density to determine the
fate of cells derived from individual clusters. At that time, FGF2 was
omitted from the medium to allow differentiation (McKinnon et al.,
1990).
Immunocytochemistry. Antibodies included mouse IgG anti-GD3 [gift
of J. Goldman (Columbia University Medical School) (Goldman et al.,
1984); 1:200 dilution], A2B5 mouse IgM (Boehringer Mannheim, India-
napolis, IN; 1:100 dilution), O4 mouse IgM [gift of I. Sommer (Max
Delbru¨ck Center for Molecular Medicine) (Sommer and Schachner,
1981; 1:15 dilution], rabbit anti-GFAP (Chemicon; 1:200 dilution), rabbit
anti-nestin [gift from R. McKay (NINDS, NIH) (Hockfield and McKay,
1985); 1:200 dilution], rabbit anti-PDGF receptor-a (PDGFRa) [gift
from K. Heldin, Ludwig Institute for Cancer Research (Nishiyama et al.,
1996); 1:500 dilution], and mouse IgG1 anti-MAP2 [clone AP20, recog-
nizing a and b isoforms (Boehringer), 1:100 dilution; and clone HM-2,
recognizing a, b, and c isoforms (Sigma), 1:100 dilution].
Live or fixed cells were incubated with primary antibodies (Abs)
against surface antigens for 30 min at 4°C, rinsed three times with PBS,
Table 1. Antigenic characteristics of neonatal rat cells immunopanned
for PSA-NCAM antibody
% of total cells
(mean 6 SEM)
% of PSA-NCAM1
cellsa (mean 6 SEM)
PSA-NCAM
(n 5 14 experiments) 87.0 6 4
GD3 (n 5 8) 15.0 6 8 14.2 6 8.4
A2B5 (n 5 3) 11.7 6 2 —b
O4 (n 5 10) 7.9 6 5.4 —b
GFAP (n 5 10) 2.9 6 1.4 1.9 6 1.2
Nestin (n 5 7) 80.6 6 6 85.4 6 6.7
PDGFRa (n 5 4) 93.2 6 4.6 96.2 6 3.7
MAP2b (clone AP20)
(n 5 5) 2.6 6 1.7 3.5 6 1.9
MAP2abc (clone HM-2)
(n 5 3) 80.3 6 12.9 ND
ND, not determined.
a By double or triple labeling of panned cells with anti PSA-NCAM antibody and
antibodies to the other antigens listed.
b The percentage of O41 or A2B51 cells from PSA-NCAM1 cells could not be
determined because all three antibodies are of mouse IgM class. However, most
O41 cells did not express nestin and therefore probably do not bear PSA-NCAM on
their surface.
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and then exposed to appropriate rhodamine- or fluorescein-conjugated
secondary Ab for 30 min at 4°C. After PBS washes they were fixed and
permeabilized in 4% formaldehyde and 0.1% Triton X-100 for 15 min (in
cases where cytoskeleton components were detected, the cells already
fixed in formaldehyde were fixed again and permeabilized for 10 min at
220°C in 5% acetic acid/95% ethanol). The cultures were then incubated
with primary Abs against cytoplasmic antigens for 30 min at room
temperature, washed, and exposed to AMCA-conjugated (and/or
fluorescein-conjugated, if not used for surface antigen) secondary Ab.
Triple immunofluorescence was made possible by using primary Abs of
mouse IgM and IgG classes and a rabbit Ab. Rhodamine-conjugated goat
anti-mouse IgM (Jackson ImmunoResearch, West Grove, PA; m-chain
specific, no cross-reaction with IgG, 1:100 dilution) was used to detect
mouse IgM (anti-PSA-NCAM, A2B5, and O4 Ab). Biotin-labeled goat
anti-mouse IgG (Jackson; FCg fragment specific, no cross-reaction with
mouse IgM, 1:100 dilution), followed by fluorescein–streptavidin (Vec-
tor, Burlingame, CA, 1:200), was used to detect GD3 and both anti-
MAP2 monoclonal antibodies. Fluorescein-conjugated goat anti-rabbit
IgG (Jackson; no cross-reaction with mouse Ig, 1:200 dilution) was used
to detect nestin and PDGFRa. 7-Amino-4-methylcoumarin-3-acetic acid
fluorophore-conjugated donkey anti-rabbit IgG (Jackson; no cross-
reaction with mouse Ig, 1:100 dilution) was used to detect GFAP. For
each preparation of cells, immunopanned cells were plated as a centered
drop on 35 mm coated dishes to attach for 1–2 hr and then stained with
PSA-NCAM Abs (1:200 dilution) combined with other Abs to enable
quantification of percentage of positive cells from total and from PSA-
NCAM1 cells. Clusters that were grown in Labtek wells were washed
very gently because they were loosely attached to the surface.
For identification of the different CNS cell type in differentiated
clusters, three triple-labeling combinations were used: (1) O4 for oligo-
dendrocyte lineage cells (visualized with rhodamine), MAP2 for neu-
rons (clone AP-20, fluorescein) and GFAP for astrocytes (AMCA); and
(2) A2B5 for O-2A progenitors and type 2 astrocytes (rhodamine), GD3
for O-2A cells (fluorescein) and GFAP for astrocytes (AMCA). The
counting was performed blind. In the neural stem cells experiments (see
Fig. 6), at least 300 cells per plate were counted in random fields. In the
experiments with PSA-NCAM-positive and -negative cells (shown in Fig.
7), all cells that had migrated out of each adherent cluster on the culture
dish were counted by scanning all nonoverlapping microscopic fields (to
avoid double counting). One-tailed unpaired Student’s t tests were per-
formed using InStat 2.01 software (Graphpad software, 1993) or Excell 5.0.
BrdU incorporation. Cell proliferation was quantified by BrdU incor-
poration index (McKinnon et al., 1990). Cultures were incubated for 16
hr with 10 mM BrdU (Sigma) in DMEM. At the end of incubation period
the cells were fixed for 10 min in 95% ethanol /5% acetic acid. DNA was
denaturated for 10 min in 2N HCl and then neutralized for 10 min with
0.1N sodium borate, pH 8.5. Cells were incubated for 30 min with
anti-BrdU antibody (Becton Dickinson, Le Pont-de Claix, France; 1:50
dilution), followed by 30 min in a fluorescein-conjugated goat anti-mouse
IgG antibody (Chemicon; 1:100 dilution). In most experiments, fixed
cells were counterstained for 10 min with 1 mg/ml propidium iodide in
0.1% sodium citrate buffer to facilitate cell counting by the visualization
of cell nuclei. When BrdU labeling was combined with surface labeling,
cells were first fixed in 4% formaldehyde and incubated with PSA-
NCAM antibody (dilution 1:250) for 45 min, followed by washing and
incubation with rhodamine-conjugated anti-mouse IgM (dilution 1:100).
The clusters were then post-fixed with acid–alcohol and processed for
BrdU labeling as described above.
MTT assay. Viable cells and cell clusters were identified in situ and
then quantified colorimetrically by the MTT assay. MTT is a tetrazolium
salt that is cleaved in mitochondria of metabolically active cells to form
a formazan dye. MTT (5 mg/ml; Boehringer) was added to cultures
grown in 96-well plates and incubated for 4 hr in 37°C. Cultures were
then visualized under an inverted microscope to count single cells or
clusters of approximately three cells that contained MTT1 cells in seven
random fields/well. The cultures were then incubated overnight in solu-
bilization solution (10% SDS, 10 mM HCl, added in 1:1 ratio). Spectro-
photometrical absorbance was measured in 550 nm using an ELISA
reader.
Terminal deoxynucleotidyl transferase (TdT)-mediated biotinylated UTP
nick end labeling (TUNEL) assay. DNA fragmentation characteristic of
cell death by apoptosis was detected in situ by the TUNEL method
[Gavrieli et al., 1992 (Boehringer Mannheim kit)]. Briefly, fixed cells (4%
formaldehyde) were permeabilized for 2 min with 0.1% Triton X-100 in
sodium citrate buffer, washed twice, and then incubated for 1 hr in 37°C
with TdT and fluorescein-labeled nucleotides. DNase-treated cultures
served as positive controls, and cultures that were incubated without TdT
served as negative controls.
RT-PCR. Total cellular RNA was extracted using the RNeasy Kit from
Qiagen (Courtaboeuf, France) and was quantified spectrophotometri-
cally. For reverse transcription, 1 mg of total RNA was used in a 20 ml
reaction containing either 500 ng of oligo(dT)12–18 or 250 ng of random
hexamers, 10 mM DTT, dNTP mix (dATP, dCTP, dGTP, dTTP, each at
0.5 mM), first-strand buffer (Life Technologies), and 200 U of Superscript
II reverse transcriptase (Life Technologies). The mixture was incubated
for 1 hr at 42°C. After 15 min of denaturation at 70°C, 1.5 ml of the cDNA
was used in a 50 ml “hot-start” PCR reaction containing the PCR buffer,
appropriate MgCl2 concentration, 250 ng of each primer, 0.2 mM dNTP
Figure 1. A–C, Immunofluorescence staining of neonatal neural precursors immediately after immunopanning. A, Of the cells identified by phase
microscopy in this microscopic field, 32 of 36 (89%) are PSA-NCAM1. B, Only four cells (11%) in the same field are GD31. C, In this other field, 13
of 15 cells are positive with clone HM-2 anti-MAP2, which detects MAP2abc isoforms. D–G, Phase micrographs showing progressive growth of
PSA-NCAM1 immunopanned cells into clusters on a nonadherent surface, during the first week in culture with FGF2. D, The cells at plating day are
separated into single cells: E, after 1 d, some cells have divided; F, after 3 d, there are small cell clusters; G, after 1 week, larger cell clusters are observed.
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Figure 2. A–C, Mitosis and differentiation of neonatal neural precursors grown in EGF and FGF2. A, A typical proliferating cluster of PSA-NCAM1
cells (red) with many BrdU1 nuclei ( green). B, Clusters of cells are nestin1 ( green). Nuclei are counterstained with Hoechst (blue). C, EGF expanded
clusters also had many PSA-NCAM1 cells (red) with BrdU1 nuclei ( green), although a few of these are also associated with PSA-NCAM-negative cells
(lef t). D–G, Migration and differentiation of neural precursors after adhesion were studied after triple labeling for 04/MAP2/GFAP except in E. Clusters
were attached to glass to perform the staining and are indicated by Cl. D, E, PSA-NCAM immunopanned cell cluster grown for (Figure legend continues)
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mix, and 2.5 U of Taq DNA polymerase (Perkin-Elmer, Paris, France).
The tube was placed in a Perkin-Elmer 9600 cycler, and 35 cycles (94°C
for 45 sec, appropriate annealing temperature for 45 sec and 72°C for 1
min) were followed by a final extension time at 72°C for 10 min. Ten
microliters of the reaction were electrophoresed on agarose TAE gel and
stained with ethidium bromide. The following primers were used with
the expected PCR product length in base pair (bp): THRa1: TGGC-
CCAAGCTGCTGATGAAGGT (forward), GACTTCCTGATCCTCA
AAGA-CCT (reverse), 143 bp; THRa2: GGAAGACGACAGCAGT
GAGGCAAG (forward), GCCT-TGCCTGCCAGGTC-CTCGCA (re-
verse), 89 bp; THRb1: GGAATGCCAGAGCTGAAGAG (forward),
CGTCTGGATCCAGATGGAAT (reverse), 262 bp; THRb2: GG
CTGCTGGTGG-TTATTCAT (forward), GTCCAGGCCTGTTCCA
GATA (reverse), 319 bp; FGFR1: TGCCG-TATGTCCAGATCC (for-
ward), CTTGTAGATGATGACGGAGC (reverse), 278 bp; FGFR2:
AACACCACGGACAAAGAGATT(forward), GTTATCCTCACCAG
CGGG(reverse), 392 bp; FGFR3: AGATGCTGAAAGATGATGC
GAC (forward), TGCCATCCACTTCACAGGTAG (reverse), 464 bp;
FGFR4: CTGTTTCATCAGCATTTGAC (forward), AAATGCC
TTGTTCT-TCTGTC (reverse), 482 bp; b-actin: commercial primers
(Stratagene, Montigny-le-Bretonneux, France), 661 bp.
Oligo(dT)-primed cDNA was used for all PCR reactions except for
THRb, where random hexamers-primed cDNA was amplified. The an-
nealing temperatures were 62°C for FGFR primers, 63°C for THRa
primers, and 57°C for TRHb primers. MgCl2 concentration was 1.5 mM
in all cases, except for the THRa1 reaction which contained 2 mM
MgCl2. The identity of the amplified products was checked by digestion
with appropriate restriction enzymes. To ensure that observed PCR
signals were not caused by amplifying contaminating genomic DNA,
control RT-PCR experiments were performed in which cDNA was syn-
thesized without reverse transcriptase.
RESULTS
Antigenic characterization of PSA-NCAM1
immunopanned cells
To obtain highly enriched populations of pre-progenitors from
the newborn rat brain, PSA-NCAM1 cells were immunopurified
from mixed glial cultures established at birth. PSA-NCAM is
expressed on most CNS cells at early stages of differentiation, but
when mixed glial cultures are set up, most neurons die. Many cells
growing on top of the astrocyte layer were expressing PSA-
NCAM. These cells were shaken off and immunopurified with
PSA-NCAM antibody 2–3 d after establishment of the neonatal
brain culture to enrich for brain precursors with properties close
to those present at birth. Immunopurification of PSA-NCAM1
cells resulted in selection of 10–30% of the cells shaken off from
the neonatal brain cultures.
Table 1 summarizes the phenotype of the immunopanned cells.
PSA-NCAM1 cells constitute a mean of 87% of this population
(Fig. 1A). This percentage is likely to be an underestimate be-
cause trypsinization of cells from the panning plates may cleave
off membrane NCAM molecules bearing PSA, and/or PSA
epitopes may be masked by the secondary antibody (used during
panning) and not be available for detection by the fluorescent
secondary antibody. The great majority of PSA-NCAM1 cells
were positive for the intermediate filament protein nestin, which
is expressed in rat embryonic neural precursors (Hockfield and
McKay, 1985). Most immunopurified cells expressed PDGFRa,
which was initially described as specific for 0–2A progenitors
(Pringle et al., 1992; Nishiyama et al., 1996) but has also been
detected recently on uncommitted neural precursors (Williams et
al., 1997). A mean of 15% of the cells expressed the O-2A
progenitor cell marker GD3 (Fig. 1B), ;12% expressed the
Figure 3. Growth of pre-progenitor clusters, quantified by the MTT
assay after 2 weeks in culture. A, Dose–response curve with optical
density measurements (which represent total number of viable cells at
each concentration) shows a dose-dependent increase in the proliferative
response between 0.1 and 10 ng/ml FGF2 with the response leveling off
above 10 ng/ml. B, Counting the number of MTT1 clusters in the tissue
culture dish shows that 0.1 ng/ml FGF2 recruited the same number of
cells to grow into cell clusters as 10 ng/ml. C, Cell cluster size was much
larger with 10 ng/ml FGF2 than with 0.1 ng/ml.
4
2 weeks in FGF2 and differentiated for 5 d. In D, many GFAP1 astrocytes (blue) have migrated out of the central cluster (Cl ) and are surrounded by
O41 oligodendrocyte lineage cells (red) but no neurons (photomontage of 4 fields). E, After triple labeling for A2B5/GD3 and GFAP, another cluster
(Cl ) shows many GFAP1 (blue) type 1 astrocytes radiating from its center; some of these are type 2 astrocytes because they also stain with A2B5 Ab
(red). GD31 processes ( green) of O-2A progenitors are radiating out of the cluster. F, PSA immunopanned neural precursors grown in EGF and
differentiated for 7 d also show glial populations of astrocytes (blue) and oligodendrocytes (red) in the outgrowth. No neurons were formed by this cluster.
G, In contrast, PSA-NCAM-negative (unpanned cells) neural precursors grown in EGF give rise to neurons (MAP2, green), astrocytes (blue), or
oligodendrocytes (red) (see Fig. 6). Similar results were obtained with striatal neural stem cells (see Fig. 7). Magnification: A, 5303; B, 4153; C, 3653;
D, 1253; E, 2103; F, 1903; G, 3603.
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ganglioside identified by the A2B5 antibody, and ;8% of the cells
were positive with the O4 Ab. Thus most of these immunopuri-
fied PSA-NCAM1 cells were negative for oligodendrocyte pro-
genitor markers. In addition, only a small percentage of cells
belonged to other neural lineages, as detected by the astrocytic
marker GFAP and the neuronal specific marker MAP2ab (clone
AP20) (Table 1). Interestingly, most cells were stained by another
MAP2 antibody (clone HM-2), which recognizes the a, b, and c
isoforms of MAP2 (Fig. 1C). This suggests that the low molecular
weight isoform MAP2c is expressed in these early precursor cells,
in agreement with the recent observation on transient expression
of MAP2c during oligodendrocyte development (Vouyiouklis
and Brophy, 1996). In conclusion, the combined approach of
shaking neonatal brain cultures followed by PSA antibody immu-
nopanning resulted in high enrichment for cells with markers
characteristic of early neural precursors [nestin1 , PDGFRa1
(Williams et al., 1997, Murray and Dubois-Dalcq, 1997)] and
lacking O-2A progenitor markers. This population of cells will be
referred to as pre-progenitors or PSA-NCAM1 cells.
FGF2 promotes the growth of pre-progenitors
into clusters
PSA-NCAM1 cells grew with FGF2 into progressively larger
clusters when cells were plated on uncoated tissue culture dishes
(Fig. 1D–G). Pre-progenitor clusters could be grown for .2
weeks with little migration and differentiation of cells outside of
clusters. They were loosely attached to the surface and subse-
quently detached and floated like neurospheres (Weiss et al.,
1996). Cell viability assay by MTT staining in situ showed that
33% of immunopanned cells were viable after 1 d and 11% were
viable after 3 d. Only a small fraction of these cells developed into
clusters of MTT1 cells (#5%), which contained essentially PSA-
NCAM1, nestin1 cells similar to those that we purified initially
(Fig. 2A,B). Using the quantitative MTT assay, half-maximal
proliferation of pre-progenitors was observed in the 1–10 ng/ml
FGF2 range, with the dose–response curve reaching a plateau at
10 ng/ml (Fig. 3A). A similar dose–response curve was obtained
for PDGF (data not shown). In situ MTT staining showed that 0.1
ng/ml FGF2 could recruit the same percentage of cells to form
clusters as higher FGF2 concentrations, probably through a sur-
vival effect (Fig. 3B). However, 10 ng/ml FGF2 induced the
growth of larger clusters than 0.1 ng/ml FGF2 (Fig. 3C), because
of its effect on cell mitosis demonstrated by the BrdU labeling
assay (Fig. 2A). Similarly, EGF (at 20 ng/ml) induces growth of
pre-progenitor clusters and DNA synthesis (Fig. 2C). The recruit-
ment of cells to form clusters with EGF was identical to that
described for FGF2 (data not shown).
Pre-progenitor cell growth is dependent on
thyroid hormone
The MTT assay was used to quantify PSA-NCAM1 pre-
progenitor cell growth with or without T3 (Fig. 4A). The combi-
Figure 4. T3 enhances the mitogenic ef-
fect of FGF2 on PSA-NCAM1 pre-
progenitor cells. A, MTT colorimetric as-
say for quantitation of cell growth in
various conditions. One representative
assay (out of 3 experiments) is shown
with mean 6 SD of optical density mea-
surement (n 5 4 samples per condition).
Neither T3 nor FGF2 alone stimulated
growth but the combination of the two
factors led to enhanced proliferation.
PDGF induced similar growth as FGF2.
B, TUNEL assay for apoptosis after 3 d
in culture in various conditions. Values
are the mean 6 SEM of three experi-
ments. T3 alone did not increase the per-
centage of TUNEL negative cells (i.e.,
living cells) as compared with control
conditions. FGF2 alone caused a small
(statistically nonsignificant) increase in
survival. The combination of the two fac-
tors significantly increased survival ( p 5
0.075 as compared with FGF2 without
T3). C, BrdU incorporation index after
3 d in culture. Values are mean 6 SEM
of three experiments. T3 alone was not
mitogenic on its own. FGF2 alone slightly
increased BrdU incorporation. The com-
bination of FGF2 and T3 significantly
and synergistically enhanced BrdU in-
corporation ( p 5 0.02 as compared with
FGF2 without T3). D, Quantitation of
MTT1 cell clusters observed in the dish
after 1 week in culture. Values are the
mean 6 SEM of three experiments.
Again, T3 did not induce cell cluster for-
mation; FGF2 alone showed only a small
increase in their number, but the combi-
nation of the factors caused a large in-
crease in the number of cell clusters that
were formed ( p 5 0.0003 as compared
with FGF2 without T3).
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nation of FGF2 and T3 led to maximal proliferation, whereas
either one of the factors alone produced significantly lower
growth. To determine how T3 affects the response of pre-
progenitors to FGF2, we assayed cell survival by the TUNEL
method at 3 d in vitro, proliferation by BrdU incorporation be-
tween 3 and 4 d, and the formation of MTT1 clusters at 7 d (Fig.
4B–D). In the absence of T3 and FGF2, ;1 cell in 10 survived
and 2% of total cells were in DNA synthesis after 3 d in vitro (Fig.
4B,C), whereas only ;1 out of 330 of the initially plated cells had
grown in clusters after 7 d (Fig. 4D). Addition of T3 to the culture
medium did not significantly change any of these parameters.
When only FGF2 was added, survival rate was slightly higher and
2.5-fold more cells were labeled with BrdU, but these differences
were not statistically significant (Fig. 4B,C). However, a 3.3-fold
increase over control was observed in the number of cells that
developed into clusters at 7 d ( p 5 0.02) (Fig. 3D). In cultures
treated with both FGF2 and T3, survival was increased 1.7-fold
over untreated control and 1.5-fold over cells treated with FGF2
alone ( p 5 0.0075) (Fig. 4B). BrdU incorporation index was
increased 3.8-fold over cells treated with FGF2 alone ( p 5 0.02)
(Fig. 4C). Moreover, 4.3 times more cells formed clusters at 7 d as
compared with cultures treated with FGF2 alone ( p 5 0.0003)
(Fig. 4D). Cluster size after 3 d was four cells on average and
approximately half of them incorporated BrdU. Therefore, the
larger percentage of TUNEL (2) cells in the FGF2 1 T3 con-
dition probably is attributable mostly to enhanced proliferation.
The results suggest that T3 did not have a direct survival or
mitogenic effect on PSA-NCAM1 pre-progenitor cells but could
enhance the proliferative response of these cells to FGF2.
Expression of thyroid hormone receptor and FGF
receptor genes in pre-progenitor cells
Because T3 enhanced the mitogenic response of pre-progenitors
to FGF2, we examined whether there is a developmental stage-
specific pattern of thyroid receptor subtype expression in our in
vitro system. Thyroid hormone effects are mediated by products of
two THR genes, each generating two isoforms by alternative
splicing. THRa has been implicated in mitosis of neural precur-
Figure 5. Expression of thyroid hormone receptors (THRs) and FGF receptors (FGFRs) in pre-progenitor cells at various stages of growth and
differentiation. RNA was isolated from PSA-NCAM1 cells immediately after immunopanning (panned cells) from clusters of pre-progenitors that were
grown for 2 weeks in the presence of FGF2 and T3 (2wk clusters) and from clusters that were grown as above and then differentiated for 5 d in the
presence of T3 and absence of FGF2 (diff. clusters). A, RT-PCR for THRa1, -a2, -b1, and -b2, and b-actin. Equally strong signal intensities of b-actin
were detected in the various RNA preparations as shown in the right panel in A. Both isoforms of THRa and THRb are detected in these RNA
preparations. THRa1 and THRb2 signals were decreased in differentiating cell clusters compared with immunopanned cells. THRa2 and -b1 signals
are equally strong in all three cell preparations. B, RT-PCR for FGF receptors. FGFR1, FGFR2, and FGFR3 but not FGFR4 are expressed during the
three developmental stages of pre-progenitor growth and development. SM, Molecular size marker (fx174 DNA digested with HaeIII).
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sors (Lezoualc’h et al., 1995), whereas changes in THRbs have
been correlated with oligodendrocyte maturation and with myeli-
nation (Forrest et al., 1991; Baas et al., 1994; Barres et al., 1994).
THR expression was studied by RT-PCR in cells at three devel-
opmental stages: PSA-NCAM1 cells immediately after immuno-
panning and PSA-NCAM1 cell clusters grown for 2 weeks in
FGF2 with T3 and in cell clusters that have been differentiating
for 5 d on polyornithine-coated dishes without FGF2 (Fig. 5A).
Both THRa and THRb isoforms (a1, a2, b1, b2) were detected
in these three developmental stages. Using the signal intensity of
b-actin as a semiquantitative reference for the amount of RNA,
we found in two different RNA preparations that THRa1 and
THRb2 transcripts produced stronger signals in immunopanned
cells than in differentiating cell clusters. Therefore, the expression
of THRsa1 and THRb2 may decrease when pre-progenitors stop
to divide and differentiate. THRa2, which does not bind T3, and
the THRb1 isoforms showed similar signal intensity at the three
developmental stages examined.
One way by which T3 can exert a permissive effect on FGF2
action is by inducing the expression of FGF receptors (FGFRs) in
the cells. We therefore examined whether the FGF- and T3-
induced growth of immunopanned cells into clusters is associated
with changes in FGFR subtype expression. Using RT-PCR, we
detected FGFR1, FGFR2, and FGFR3 but not FGFR4 in the
three developmental stages of our culture system (Fig. 5B). As a
positive control, FGFR4 transcripts were detected in RNA from
rat lung (data not shown). The results did not show qualitative or
quantitative significant differences in FGFR expression between
pre-progenitors before and after they were grown with FGF2 and
T3. Thus T3 did not selectively enhance transcripts of one type of
FGFR nor did it seem to increase their mRNA expression level in
cell clusters.
In recent experiments, the Erb B1 receptor for EGF was also
detected by RT-PCR in isolated PSA-NCAM clusters, after 2
weeks of growth and in differentiating clusters (data not shown).
The fate of PSA-NCAM1 cells differs from that of
neural stem cells and of PSA-NCAM2 cells
We then investigated the fate of clusters/spheres of pre-
progenitors after adhesion and compared it with the fate of neural
stem cells isolated from newborn rat striata and grown in neuro-
spheres with FGF2 or EGF (Weiss et al., 1996). In all cases,
spheres were grown in growth factors for 1–2 weeks and then
transferred onto a dish or coverslip coated with polyornithine in
the same medium without growth factors. Within a few hours,
cells migrated out of the clusters/spheres and grew processes,
often showing a bipolar shape. After 5 d, there were many
differentiated cells in the outgrowth that were analyzed by triple-
label immunofluorescence with O4, GFAP, and MAP2
antibodies.
The great majority of pre-progenitor clusters gave rise to
oligodendrocyte lineage O41 cells as well as GFAP1 astrocytes.
Usually, astrocytic processes radiated out from the core of the
cluster, and multipolar O41 cells of the oligodendrocyte lineage
and GFAP1 astrocytes surrounded the clusters (Fig. 2D). Triple
labeling with GD31, A2B5, and GFAP antibodies showed the
presence of bipolar GD31 0–2A progenitors in the outgrowth,
where GFAP1/A2B52 type 1 and occasionally GFAP1/A2B51
type 2 astrocytes could be found as well. Type 2 astrocytes were
found in 6–19% of the clusters in three experiments (Fig. 2E).
Only rarely were MAP21 neurons encountered in these cultures.
PSA-NCAM1 pre-progenitors that were expanded with EGF
Figure 6. Striatal neural stem cells grown in FGF2 for 7 d were differ-
entiated for 5 d without FGF2. Spheres cultured with or without T3 were
analyzed after triple label for 04/MAP2/GFAP, and the ratio of the
different cell types was calculated (see Materials and Methods). Fewer
neurons formed (**p , 0.001) and more oligodendrocytes emerged (*p ,
0.05) in the presence of T3 than without. Three independent experiments
were analyzed in the Student’s t test. Figure 7. Cell fate of PSA-NCAM-positive and -negative neonatal pre-
cursors grown in clusters/spheres with EGF or FGF2 and analyzed as in
Figure 6. With each of these growth factors, PSA-NCAM immunopanned
cells (panned) gave rise mostly to oligodendrocytes and astrocytes,
whereas PSA-NCAM negative cells (unpanned) gave rise to the three
CNS cell types. Within each growth factor group, the ratio of neuronal
cells was significantly higher in unpanned cells (*p , 0.05). In the EGF
group, the ratio of oligodendrocytes was significantly lower in unpanned
than panned cells (*p , 0.05), whereas this significance was not reached
in the FGF2 group (also see Fig. 6). Three independent experiments were
analyzed in the Student’s t test.
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generated a similar glial population after differentiation (Fig. 2F).
The fate of pre-progenitors grown without T3 could not be
studied because of their inability to expand in the absence of this
hormone.
We then examined the fate of neural stem cell spheres grown
with FGF2 and T3 like the pre-progenitors and found that after
adhesion these spheres generated mostly astrocytes (51%) and
oligodendrocytes (44%), whereas only 5% neurons were observed
(Fig. 6). To determine the influence of growth factors and T3 on
stem cell fate, we also analyzed which CNS cells were generated
by similar neurospheres grown in FGF2 but in the absence of T3
(Fig. 6). In contrast to PSA-NCAM1 cells, neural stem cell
growth did not require T3. In the absence of this hormone,
adherent neurospheres generated 30% neurons, whereas the pro-
portion of oligodendrocytes fell to 15% (Fig. 6). Neural stem cells
grown in EGF, the mitogen most often used to grow neural stem
cells in spheres (Weiss et al., 1996), also generated the three CNS
cell types in the absence of T3 (data not shown). Thus T3 added
to neural stem cells during their growth and differentiation
caused a significant increase in the percentage of oligodendro-
cytes, mainly at the expense of neurons. This correlates with the
observation that T3 can instruct multipotential neural stem cells
to become mostly oligodendrocytes (Johe et al., 1996). Alterna-
tively, T3 could favor the survival of pre-progenitors of oligoden-
drocytes generated by stem cells, whereas neuronal progenitors
would not depend on T3 for their survival. It was also shown that
FGF2 at 10 ng/ml can drive stem cells into a mostly oligodendro-
cyte fate (Qian et al., 1997). Thus one interpretation of our data
would be that neural stem cells as well as pre-progenitors could
adopt a mostly glial fate when expanded with FGF2 and T3.
We therefore compared the fate of PSA-NCAM-positive cells
with that of PSA-NCAM-negative neonatal neural precursors,
which we predicted would contain the neonatal stem cell popu-
lation. To this goal, we purified PSA-NCAM1 cells by immuno-
panning (as above) and collected the cells nonadhering to the
anti-PSA antibody-coated plates (called “unpanned”) before
growing both populations in EGF or FGF2 on nonadherent
substrates. Because growth of pre-progenitors is dependent on
T3, this hormone was added to all growth media. We then
analyzed the fate of these two distinct cell populations by triple
immunolabeling 5 d after adhesion and withdrawal of the mito-
gen. We observed a striking difference between the fate of PSA-
NCAM antibody panned and unpanned precursors independent
of the mitogen used (Fig. 7). PSA-NCAM-negative cells were
multipotential and could generate neurons, whereas PSA-
NCAM1 precursors generated mainly glia (Fig. 2F,G). Interest-
ingly, the ratio of the three CNS cell types varies between EGF
and FGF2 spheres grown from unpanned cells. In FGF2-grown
spheres, the ratio of neurons was two times lower than in those
grown in EGF, as also observed with neural stem cells (Fig. 6). In
both cases, the increase in the ratio of oligodendrocytes was
proportional to the decrease in the ratio of neuronal cells. Taken
together these results suggest that under our experimental con-
ditions, unpanned PSA-NCAM-negative cells correspond mostly
to multipotential neural stem cells and that T3 and FGF2 may
promote a glial fate in these neonatal stem cells. In contrast,
PSA-NCAM1 cells are restricted to a glial fate independent of
the mitogen used to grow them.
DISCUSSION
We describe here the growth and fate of neonatal brain PSA-
NCAM1 precursors grown in clusters/spheres that differentiate
after adhesion to a substrate. The antigenic profile of these
precursors closely resembles that of pre-progenitors known to
generate O-2A progenitors (Grinspan et al., 1990, 1995). Such
neonatal pre-progenitors represent a transition stage between
neural stem cells and O-2A progenitors (Table 2). Features re-
sembling those of neural stem cells are the expression of nestin,
their dependence on FGF2 or EGF for proliferation, and their
ability to grow on nonadherent surface into clusters that eventu-
ally float like stem cell neurospheres (Vescovi et al., 1993; Gritti
et al., 1996; Johe et al., 1996). Yet PSA-NCAM1 neural precur-
sors differ from PSA-NCAM-negative multipotential neural stem
cells because they have a more restricted potentiality, generating
mostly cells of the oligodendrocyte and astrocyte lineages.
Growth factors and thyroid hormone can influence cell fate in
both types of neonatal precursors: T3 is not required for the
growth of true multipotential neural stem cells but may instruct
these to become glia (Johe et al., 1996; this study). In addition, T3
and FGF2 act together to promote the development of cells of the
astrocyte and oligodendrocyte lineage from neural stem cells.
This situation is different from that of PSA-NCAM1 neural
precursors, which require T3 to enhance their growth and gen-
erate mostly astrocytes and oligodendrocytes independent of the
Table 2. Comparison between neural stem cells, pre-progenitors, and O-2A progenitor properties in vitro
Embryonic Neural Stem Cells Neonatal Brain Pre-progenitors CNS O-2A Progenitors
Shape in phase
microscope




Bipolar with long processes and motile
Antigenic phenotype Nestin1 PSA-NCAM and
nestin1 A2B52, GD32
Progressive loss of PSA-NCAM
and nestin, but A2B51, GD31
Mitogenic growth
factors (GF)
FGF2, EGFa FGF2, PDGF, EGF FGF2, PDGF, NT3, IGF-1
Thyroid hormone
effects
Can induce an OL fateb Enhances FGF2-mediated
growth






OL and astrocytes OL and type 2 astrocytes
OL, Oligodendrocyte.
a Weiss et al., 1996.
b Johe et al., 1996.
c Barres et al., 1994; Hudson et al., 1996.
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factor used to grow them. Thus appearance of PSA-NCAM at the
surface of neonatal brain precursors coincides with their restric-
tion to a mostly glial fate.
Thyroid hormone can act at multiple stages of oligodendrocyte
development. T3 enhancement of growth factor-driven prolifer-
ation of PSA-NCAM1 neonatal precursor differs from its effects
on O-2A progenitors from optic nerve. In this case, T3 limits the
proliferative potential of O-2A progenitors in the continued pres-
ence of mitogenic growth factors (Barres et al., 1994; Baas et al.,
1997), whereas in the absence of T3, fewer oligodendrocytes
develop in these cultures (Ahlgren et al., 1997). Such distinct T3
effects might be mediated by different THRs. THRa isoforms are
expressed early in brain development, whereas THRb appears
later and in a more restricted pattern (Mellstro¨m et al., 1991;
Bradley et al., 1992). THRa (most precisely the a1 isoform) but
not THRb was shown to mediate mitogenic effect on chick
neuroblasts (Lezoualc’h et al., 1995). The RT-PCR data shown
here, although not quantitative, suggest that THRa1 expression
was strongest during the proliferative stage of pre-progenitor
growth and decreased on differentiation. In the rat brain, THRb1
mRNA sharply increases between E19 and postnatal day 10,
suggesting a correlation with the initiation of myelination (Strait
et al., 1990; Forrest et al., 1991; Mellstro¨m et al., 1991). THRb1
expression is induced on differentiation of oligodendrocytes
(Baas et al., 1994; Besnard et al., 1994), whereas THRb2 isoform
is detected in O-2A progenitors but not in mature oligodendro-
cytes (Barres et al., 1994). Similarly, our data suggest that
THRb2 expression may be downregulated after pre-progenitor
clusters have differentiated. It is also possible that T3 may induce
synthesis of growth factors such as PDGF or neurotrophins in
neural precursor clusters/spheres (Alvarez-Dolado et al., 1994;
Iglesias et al., 1995; Neveu and Arenas, 1996). Thus, in our
system, T3 could exert an indirect trophic effect by inducing the
synthesis of specific growth factors by pre-progenitor cells. Pre-
liminary RT-PCR analysis detected PDGF-A and PDGF-B but
not NGF or NT3 expression in growing clusters (data not shown).
The ability to respond to FGF2 appears to be common to
multipotential neural stem cells, pre-progenitors as well as O-2A
progenitors, which are committed to an oligodendrocyte fate
(Table 2). Accordingly, we found that PSA-NCAM1 pre-
progenitors express FGFR1, FGFR2, and FGFR3 but not
FGFR4, just as multipotential cortical stem cells do (Qian et al.,
1997). It is possible that T3 may enhance FGF2 effects by induc-
tion or enhancement of FGFRs expression. Complex regulation
of FGFRs in the oligodendrocyte lineage has been shown re-
cently (Bansal et al., 1996). We did not find major changes in
FGFRs transcripts levels in pre-progenitors in expansion com-
pared with those in differentiation after adhesion, but this does
not rule out changes in FGFR protein levels. PSA-NCAM1
precursors also respond to EGF and express its receptor, whereas
EGF is not a known mitogen for O-2A progenitors.
Growth of precursors in spheres can be obtained even at a stage
when these cells are committed to an oligodendrocyte fate.
GD31 rat oligodendrocyte progenitors were propagated on non-
adherent substrate in the form of “oligospheres,” particularly with
conditioned medium (CM) of a neuroblastoma cell line, B104
(Avellana-Adalid et al., 1996). In addition, EGF-grown neural
spheres from the neonatal brain can be progressively transformed
into oligospheres by growth in B104 CM (Zang et al., 1997).
When dissociated and plated on adhesive substrate, these oligo-
spheres generated typical O-2A progenitors evolving into oligo-
dendrocytes or type 2 astrocytes depending on serum concentra-
tion. Recently, the presence of PSA-NCAM1 pre-progenitors
was demonstrated in the center of mouse oligospheres (Baron-
van Evercooren et al., 1997). In our system, the growth of single
PSA-NCAM immunoselected cells on nonadherent substrate
with FGF2 (or EGF) and T3 resulted in highly homogenous
populations of pre-progenitors in the floating cell clusters. When
grafted, PSA-NCAM1 precursors are able to produce a remark-
able amount of myelin around naked axons in a focal demyeli-
nated lesion in adult rats (Keirstead et al., 1998).
The PSA-NCAM1 neural precursors characterized here in
vitro appear to correspond to the bipotential glial precursors
described in the neonatal rat brain (Goldman,1996). Neonatal
subventricular zone precursor cells can produce both astrocytes
and oligodendrocytes when they migrate into the gray matter in
vivo, suggesting the existence of a common glial precursor for
both cell types (Levison and Goldman, 1993). Pre-progenitors are
likely to originate from SVZ because these cells can be isolated
from deep cerebral white matter but not from optic nerve (Grin-
span et al., 1990). The mostly glial fate of pre-progenitors may be
caused by specific signals in the neonatal brain environment that
also trigger the expression of PSA-NCAM.
Glial-restricted precursors can also be derived from embryonic
day (E) 10.5 spinal cord (Rao and Mayer-Proschel, 1997). These
precursors were labeled by the anti-ganglioside antibody A2B5
and gave rise to astrocytes and oligodendrocytes as already sug-
gested by an earlier study (Fok-Seang and Miller, 1994). In the
neonatal brain, this antibody rarely stained immunopanned PSA-
NCAM1 precursors (Table 1). Clearly, the appearance of spe-
cific surface molecules may vary with the CNS region and the age
from which such precursors are isolated. Interestingly, lineage-
restricted neuronal precursors were also found to derive from
multipotential neural stem cells isolated from the E13.5 spinal
cord (Mayer-Proschel et al., 1997). These precursors could be
distinguished from neural stem cells by the emergence of PSA-
NCAM. This is in agreement with the proposal that embryonic
NCAM is not expressed on neural stem cells but emerges when
cells move along a particular lineage and/or restrict their fate
(Kiss and Rougon, 1997). In the neonatal rat brain, we show here
that emergence of PSA-NCAM coincides also with a restricted
fate, but at this time of CNS development when neurons are
already in place, the fate is mostly restricted to glial lineages.
In conclusion, we have first demonstrated that PSA-NCAM1
pre-progenitor cells isolated from the neonatal brain can expand
in response to FGF2 and that T3 has a permissive effect on this
FGF2-stimulated growth. We then showed that PSA-NCAM pre-
cursors differ from true multipotential stem cells in that they
mostly generate astrocytes and oligodendrocytes and behave like
bipotential glial progenitors. Such an in vitro system therefore
should allow the study of the molecular basis of decisions toward
the astrocyte and oligodendrocyte fate.
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